Ira Chalikonda
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Herpesvirus Infections and Treatments, Poxvirus research and outbreaks, Animal Virus Infections Studies, Hepatitis B Virus Studies, Circadian rhythm and melatonin
Most-Cited Works
- → Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine(2003)318 cited
- → Diurnal variation of the human adipose transcriptome and the link to metabolic disease(2009)122 cited
- → Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age(2011)59 cited
- → Measurement of cell-mediated immunity with a varicella-zoster virus-specific interferon-? ELISPOT assay: Responses in an elderly population receiving a booster immunization(2003)53 cited
- → Immunoprecipitation and Virus Neutralization Assays Demonstrate Qualitative Differences between Protective Antibody Responses to Inactivated Hepatitis A Vaccine and Passive Immunization with Immune Globulin(1997)53 cited
- → Safety, tolerability, and immunogenicity of a two-dose regimen of high-titer varicella vaccine in subjects ≥13 years of age(2006)21 cited